Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyResearch in context

Summary: Background: Although Ki-67 is a commonly used proliferation marker in breast cancer (BC), its prognostic value after neoadjuvant chemotherapy (NACT) remains unclear. This study aims to investigate the prognostic implications of Ki-67 dynamics during NACT. Methods: Patients with invasive BC...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Maria Angeliki Toli, Xingrong Liu, Davide Massa, Stefania Lando, Caroline Boman, Nikolaos Tsiknakis, Christian Tranchell, Andri Papakonstantinou, Giuseppe Fotia, Claudio Vernieri, Valentina Guarneri, Jonas Bergh, Maria Vittoria Dieci, Louise Eriksson Bergman, Alexios Matikas, Theodoros Foukakis
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-11-01
Rangatū:	The Lancet Regional Health. Europe
Ngā marau:	Breast cancer Neoadjuvant chemotherapy Ki-67 Prognosis Survival Stratification
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2666776225002248
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!